Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
151.26
-2.11 (-1.38%)
Jul 14, 2026, 12:08 PM EDT - Market open

Novartis AG Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Cash & Equivalents
6,87711,4359,5566,6567,06611,45913,6097,9039,46913,39312,40510,88512,0007,5178,7263,62513,85212,4077,2115,117
Short-Term Investments
1001551973441301,9984115322251,03529028926011,41310,37716,1334,96215,922951239
Cash & Short-Term Investments
6,97711,5909,7537,0007,19613,45714,0208,4359,69414,42812,69511,17412,26018,93019,10319,75818,81428,3298,1625,356
Cash Growth
-3.04%-13.87%-30.44%-17.01%-25.77%-6.73%10.44%-24.51%-20.93%-23.78%-33.54%-43.45%-34.84%-33.18%134.05%268.90%361.47%145.00%-24.91%-14.89%
Accounts Receivable
9,3868,9378,8449,0568,5967,4237,9668,2287,8407,1076,8199,1958,9168,0668,4228,6438,4098,0058,3778,400
Other Receivables
216205140120129133184252411426280348267268258267269278255254
Total Trade Receivables
9,6029,1428,9849,1768,7257,5568,1508,4808,2517,5337,0999,5439,1838,3348,6808,9108,6788,2838,6328,654
Inventory
6,2866,2696,4216,3075,8295,7235,9395,7475,7435,9135,6108,2287,8867,1756,7796,8806,9976,6666,8857,111
Other Current Assets
3,7423,4593,0403,4563,3582,9683,1553,0312,7592,60720,2564,5482,7852,4712,3922,5942,7472,4402,5742,687
Total Current Assets
26,60730,46028,19825,93925,10829,70431,26425,69326,44730,48145,66031,77332,11436,91036,95438,14237,23645,71826,25323,808
Net Property, Plant & Equipment
12,23812,35211,99111,82611,08710,87311,20110,62210,54210,92410,34412,27712,34812,19511,73112,20612,86113,10613,15713,344
Other Intangible Assets
40,20929,41129,03729,24027,47626,91527,90227,77526,27226,87926,41828,00330,45131,64431,88833,36734,85334,18233,95134,818
Goodwill
26,81925,56725,55125,55324,96524,75624,93025,23423,06323,34123,41629,52229,48129,30128,66829,11329,63629,59529,57229,766
Long-Term Investments
2,4312,4462,1532,1612,0952,1342,1922,1262,5822,8122,1222,4332,5552,5542,4912,5802,9063,24112,34712,014
Other Long-Term Assets
10,22810,71310,3599,6769,2107,8646,0356,0555,4285,5084,7375,2515,2924,8496,7327,5027,7265,9535,92910,265
Total Assets
118,532110,949107,289104,39599,941102,246103,52497,50594,33499,945112,697110,979112,241117,453118,464122,910125,218131,795121,209124,015
Accounts Payable
4,3224,4564,5554,5064,2614,5724,0874,1464,0624,9263,8705,3505,4265,1464,6934,9695,0835,5534,6654,811
Accrued Expenses
17,35714,98816,31915,80916,74514,05415,06713,78315,01213,16613,97415,33814,93814,79513,47512,92915,17815,67013,13813,097
Current Portion of Long-Term Debt
7,6175,6027,5208,3147,8018,2326,5667,5328,3396,1755,4588,2896,9685,9317,0557,0456,6966,2959,3379,075
Current Portion of Leases
271263264259242235247232225230210247251251248258272275277279
Other Current Liabilities
1,8071,9693,3422,8262,5701,5992,1651,9191,6501,89324,8812,6852,9662,5332,6892,4452,5782,4152,4632,371
Total Current Liabilities
31,37427,27832,00031,71431,61928,69228,13227,61229,28826,39048,39331,87530,54928,65628,16027,64629,80730,20829,88029,633
Long-Term Debt
37,44727,93522,59822,47021,66621,36623,75019,66317,19118,43618,06818,25920,39620,24419,73222,23222,79622,90223,10124,828
Long-Term Leases
1,6631,6571,6401,5941,5611,5681,5961,5601,5291,5981,4531,5451,5891,5381,5031,5521,5771,6211,6141,663
Other Long-Term Liabilities
9,1217,5306,2996,5636,6436,4946,6056,7686,5706,7716,5387,3357,5657,5928,1718,4749,3349,2429,67713,763
Total Long-Term Liabilities
48,23137,12230,53730,62729,87029,42831,95127,99125,29026,80526,05927,13929,55029,37429,40632,25833,70733,76534,39240,254
Total Liabilities
79,60564,40062,53762,34161,48958,12060,08355,60354,57853,19574,45259,04860,09958,03057,56659,90463,51463,97364,27269,887
Common Stock
736766766766766793793793793825825842842890890890901901901913
Treasury Stock
-47-50-44-33-19-53-40-25-17-41-32-52-36-92-70-60-60-48-47-65
Retained Earnings
37,82345,41443,60841,25237,62243,30642,56440,96538,89945,88337,37151,05751,25358,54460,00062,09560,69966,80255,91753,194
Total Common Shareholders' Equity
38,51246,13044,33041,98538,36944,04643,31741,73339,67546,66738,16451,84752,05959,34260,82062,92561,54067,65556,77154,042
Minority Interest
415419422698380124169818381848381788116416716686
Shareholders' Equity
38,92746,54944,75242,05438,45244,12643,44141,90239,75646,75038,24551,93152,14259,42360,89863,00661,70467,82256,93754,128
Total Liabilities & Equity
118,532110,949107,289104,39599,941102,246103,52497,50594,33499,945112,697110,979112,241117,453118,464122,910125,218131,795121,209124,015
Total Debt
46,99835,45732,02232,63731,27031,40132,15928,98727,28426,43925,18928,34029,20427,96428,53831,08731,34131,09334,32935,845
Net Cash (Debt)
-40,021-23,867-22,269-25,637-24,074-17,944-18,139-20,552-17,590-12,011-12,494-17,166-16,944-9,034-9,435-11,329-12,527-2,764-26,167-30,489
Net Cash Per Share
-20.89-12.37-11.48-13.08-12.16-8.95-8.95-10.04-8.55-5.82-6.02-8.19-7.99-4.20-4.33-5.12-5.60-1.23-11.61-13.50
Book Value
38,51246,13044,33041,98538,36944,04643,31741,73339,67546,66738,16451,84752,05959,34260,82062,92561,54067,65556,77154,042
Book Value Per Share
20.1023.9122.8521.4219.3921.9821.3720.4019.3022.6018.3924.7524.5627.6027.9028.4627.5130.0325.1923.93
Tangible Book Value
-28,516-8,848-10,258-12,808-14,072-7,625-9,515-11,276-9,660-3,553-11,670-5,678-7,873-1,603264445-2,9493,878-6,752-10,542
Tangible Book Value Per Share
-14.88-4.59-5.29-6.53-7.11-3.80-4.69-5.51-4.70-1.72-5.62-2.71-3.71-0.750.120.20-1.321.72-3.00-4.67
SEC Filings: 10-K · 10-Q